The Latest
-
Labcorp closes takeover of Empire City assets to fuel New York expansion
The company struck three deals in New York last year as part of its push to acquire hospital and regional testing labs.
-
Baxter cuts roughly 90 jobs at IV solutions plant that recovered from Hurricane Helene
Hospital demand for IV solutions in the U.S. is lower than before Hurricane Helene, the company said.
-
Stryker starts limited release of Mako RPS handheld knee robot
Surgeons interested in robotic technology but wanting a simpler system than existing platforms are the target market for the new device.
-
Abbott details Volt, TactiFlex data; Pulse Biosciences’ results shine
Abbott and Pulse released their findings at the AF Symposium that wrapped this weekend in Boston.
-
FDA breakthrough program starts FY2026 at steady pace
Orthopedics was the most active area over the second half of 2025, with the FDA issuing 13 breakthrough designations to devices in the therapeutic area.
-
AI in medtech is booming. Track new devices here.
The Food and Drug Administration has authorized more medical devices that incorporate artificial intelligence. Keep track of the latest developments in this database.
Updated Feb. 9, 2026 -
J&J recalls coil systems used in aneurysm treatment
Healthcare providers are advised to stop using the devices after a failure to detach was linked with four serious injuries and one death.
-
GE HealthCare expects smaller tariff impact in 2026
After taking a $245 million hit from the levies in 2025, CFO James Saccaro said the company plans more actions to mitigate their effects in 2026, including shifting its supply chain.
-
Epic rolls out AI charting tool as scribe market heats up
The vendor could prove a significant competitor in the AI notetaking space, given Epic’s leading market share in electronic health records.
-
Boston Scientific continues to see electrophysiology success despite slowdown in growth
Pulsed field ablation has fueled strong sales growth for the firm’s electrophysiology business over the past two years. However, the pace has slowed in recent quarters.
-
J&J corrects Impella heart pumps over issue linked to 22 serious injuries
The urgent correction notice is the latest in a series of actions related to the safety of Impella devices.
-
Medtronic wins expanded FDA label for 780G insulin pump
The 510(k) decision clears the device for use with ultra-rapid-acting insulins from Eli Lilly and Novo Nordisk.
-
Prices rise at surgery centers acquired by Optum: study
The full financial impact of the price hikes could exceed $67 million each year in two dozen markets, according to the new study published in Health Affairs.
-
Genetic testing takes greater share of Medicare Part B test spending: OIG
Spending on the tests, which analyze genetic material from both people and pathogens, rose 20% year over year in 2024, the analysis found.
-
Abbott receives FDA warning letter over Freestyle Libre CGMs
Abbott needs to conduct more performance testing to ensure its FreeStyle Libre devices are accurate, FDA inspectors found.
-
Medtronic to acquire CathWorks for up to $585M
The purchase will give Medtronic a larger presence in the cath lab, with a tool to help diagnose and treat coronary artery disease.
-
Beta Bionics receives FDA warning letter
The letter, which the FDA has not yet published, does not affect Beta Bionics’ ability to market, manufacture or distribute products, the company said.
-
STAAR names interim co-CEOs amid search for permanent leader
The company is looking for a new top executive after former CEO Stephen Farrell left when STAAR shareholders rejected a buyout offer from Alcon.
-
Lawsuit challenges ethylene oxide exemptions for device sterilizers
The lawsuit questions the Trump administration’s authority to make sweeping environmental exemptions without evidence.
-
Grail files for FDA approval of multi-cancer early detection test
Premarket approval could help the company secure coverage from commercial payers and Medicare.
-
ACA enrollment backslides to 23M in 2026
That’s down 5% from last year. But it’s not the nosedive some market watchers predicted, and a handful of states — notably, Texas — saw robust growth.
-
Top medtech trends to watch in 2026
From M&A to surgical robotics and user fee negotiations, the medical device industry has a busy year ahead. Check out MedTech Dive’s roundup of the top medtech trends to watch in 2026.
-
Stryker starts first cases with handheld ortho robot
Stryker expects the robot, called Mako RPS, to bring in new customers, including more ambulatory surgery centers.
-
Senseonics wins CE mark for one-year CGM
The company is hiring sales reps and transitioning staff from its former partner to support launches in Germany, Italy, Spain and Sweden.
-
Deep Dive
5 robotic surgery trends to watch in 2026
Soft tissue robotic systems designed to improve surgical precision are expanding into new specialties and increasing competition for longtime industry leader Intuitive Surgical.